How pharmaceutical companies
can improve their liquidity

In the current context of the covid-19 health crisis, many companies have put a premium on the need to maximise their profits to obtain liquidity in order to revive their economy and reduce their corporate tax burden.

 We review the tools available to improve liquidity:

• The deduction for research and development and technological innovation activities.
• Social Security rebates
• Setting up an Economic Interest Grouping (EIG).

At Euro-Funding we provide our clients with customised financial solutions that allow them to materialise the different financing instruments quickly and efficiently according to their financial context (monetisation/cash-back, participation of private financial entities, endorsements and guarantees, generation of EIGs or subrogation of credits, among others).